References and Notes
- 1
Bonsignore L.
Cottiglia F.
Lavagna SM.
Loy G.
Secci D.
Farmaco
1998,
53:
693
- 2
Horton DA.
Bourne GT.
Smythe ML.
Chem. Rev.
2003,
103:
893
-
3a
Berthelot T.
Talbot J.-C.
Laïn G.
Déleris G.
Latxague L.
J. Pept. Sci.
2005,
11:
153
-
3b
Lim NC.
Schuster JV.
Porto MC.
Tanudra MA.
Yao L.
Freake HC.
Bruckner C.
Inorg. Chem.
2005,
44:
2018
-
3c
Âguez-Ubis JCR.
Alonso MT.
Juanes O.
Brunet E.
Luminescence
2000,
15:
331
-
4a
Lévai A.
Tóth G.
Gondos T.
Jekö J.
Brahmbhatt DI.
Heterocycles
2006,
68:
1319
-
4b
Risitano F.
Grassi G.
Foti F.
Bilardo C.
Heterocycles
2001,
55:
1311
-
4c
Ismail NA.
Khalifa FA.
Magd El Din AA.
Heterocycles
1991,
32:
1101
-
4d
Yamashita M.
Okuyama K.
Kawajiri T.
Takada A.
Inagaki Yu.
Nakano H.
Tomiyama M.
Ohnaka A.
Terayama I.
Kawasaki I.
Ohta S.
Tetrahedron
2002,
58:
1497
-
4e
Nemeryuk MP.
Dimitrova VD.
Anisimova OS.
Sedov AL.
Solov’eva NP.
Traven VF.
Chem. Heterocycl. Comp.
2003,
39:
1454;
Khim. Geterotsikl. Soedin.
2003,
1652
-
4f
Mashraqui SH.
Mistry H.
Sundaram S.
J. Heterocycl. Chem.
2006,
43:
917
-
4g
Raev LD.
Frey W.
Ivanov IC.
Synlett
2004,
1584
-
5a
Jones G.
Org. React. (N. Y.)
1967,
15:
204
-
5b
Tietze LF.
Beifuss U. In
Comprehensive Organic Synthesis
Vol. 2:
Trost BM.
Fleming I.
Heathcock CH.
Pergamon Press;
Oxford:
1991.
p.341
-
5c
Bigi F.
Chesini L.
Maggi R.
Sartori G.
J. Org. Chem.
1999,
64:
1033
-
5d
Fringuelli F.
Permatti O.
Pizzo F.
Synthesis
2003,
2331
-
6a
Selim MR.
J. Chem. Res., Synop.
1998,
84
-
6b
O’Callaghan CN.
McMurry TBM.
J. Chem. Res., Synop.
1997,
78
-
6c
O’Callaghan CN.
McMurry TBM.
J. Chem. Res., Synop.
1999,
458
-
6d
Bogdal D.
J. Chem. Res., Synop.
1998,
468
-
6e
Buu-Hoi NP.
Saint-Ruf G.
Loc TB.
Xuong ND.
J. Chem. Soc.
1957,
2593
-
6f
Specht DP.
Martic PA.
Farid S.
Tetrahedron
1982,
38:
1203
-
6g
Su C.
Chen Z.-C.
Zheng Q.-G.
Synthesis
2003,
555
-
6h
Prakash Rao HS.
Sivakumar S.
J. Org. Chem.
2006,
71:
8715
-
7a
Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications
Filler R.
Kobayashi Y.
Yagupolskii LM.
Elsevier;
Amsterdam:
1993.
-
7b
Hiyama T.
Organofluorine Compounds. Chemistry and Application
Springer;
Berlin:
2000.
-
7c
Persy JM.
Top. Curr. Chem.
1997,
193:
131
-
8a
Sosnovskikh VYa.
Korotaev VYu.
Chizhov DL.
Kutyashev IB.
Yachevskii DS.
Kazheva ON.
Dyachenko OA.
Charushin VN.
J. Org. Chem.
2006,
71:
4538
-
8b
Korotaev VYu.
Kutyashev IB.
Sosnovskikh VYa.
Heteroat. Chem.
2005,
16:
492
-
8c
Chizhov DL.
Ratner VG.
Pashkevich KI.
Russ. Chem. Bull.
1999,
48, 758 ; Izv. Akad. Nauk, Ser. Khim. 1999, 762
-
8d
Yachevskii DS.
Chizhov DL.
Ratner VG.
Pashkevich KI.
Russ. Chem. Bull., Int. Ed.
2001,
50, 1233
; Izv. Akad. Nauk, Ser. Khim. 2001, 1176
-
8e
Chizhov DL.
Pashkevich KI.
Röschenthaler G.-V.
J. Fluorine Chem.
2003,
123:
267
-
8f
Pryadeina MV.
Kuzueva OG.
Burgart YaV.
Saloutin VI.
Lyssenko KA.
Antipin MYu.
J. Fluorine Chem.
2002,
117:
1
-
8g
Pryadeina MV.
Kuzueva OG.
Burgart YaV.
Saloutin VI.
Russ. J. Org. Chem.
2002,
38:
224;
Zh. Org. Khim.
2002,
38:
244
,
-
8h
Pryadeina MV.
Burgart YaV.
Kodess MI.
Saloutin VI.
Russ. Chem.Bull. Int. Ed.
2005,
54:
2841;
Izv. Akad. Nauk. Ser. Khim.
2005,
2745
- 9
Voznyi YaV.
Dekaprilevich MO.
Yufit DS.
Struchkov YuT.
Russ. Chem. Bull.
1992,
41:
1072;
Izv. Akad. Nauk, Ser. Khim.
1992,
1371
,
-
10a
Sosnovskikh VYa.
Irgashev RA.
Synlett
2005,
1164
-
10b
Sosnovskikh VYa.
Irgashev RA.
Barabanov MA.
Synthesis
2006,
2707
-
10c
Sosnovskikh VYa.
Irgashev RA.
Heteroat. Chem.
2006,
17:
99
-
10d
Sosnovskikh VYa.
Moshkin VS.
Irgashev RA.
Tetrahedron Lett.
2006,
47:
8543
-
10e
Sosnovskikh VYa.
Irgashev RA.
Khalymbadzha IA.
Slepukhin PA.
Tetrahedron Lett.
2007,
48:
6297
- 12
El Kharrat S.
Laurent P.
Blancou H.
J. Org. Chem.
2006,
71:
8637
- 13
Inokuchi T.
Kawafuchi H.
J. Org. Chem.
2006,
71:
947
- 15
Druzhinin SV.
Balenkova ES.
Nenajdenko VG.
Tetrahedron
2007,
63:
7753
11
Typical Procedure for Preparation of 6
A mixture of salicylaldehyde (5.0 mmol), ethyl trifluoro-acetoacetate (5.0 mmol) and piperidinium acetate (4 mg, 5 mol%) was refluxed in MeCN (10 mL) for 3-4 h and then diluted with H2O (30 mL). The precipitate that formed was filtered, washed with warm H2O (50 °C, 5 × 10 mL) and dried on air to give 6.
Data for Compounds 6a,d
Compound 6a: colorless crystals; mp 102-103 °C (hexane). IR (mull): ν = 3294, 1686, 1635, 1607, 1576 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.40 (t, J = 7.2 Hz, 3 H, Me), 4.38 (q, J = 7.2 Hz, 2 H, OCH2), 7.01-7.06 (m, 2 H, H-6, H-8), 7.26 (dd, J = 7.9, 1.7 Hz, 1 H, H-5), 7.39 (ddd, J = 8.2, 7.5, 1.7 Hz, 1 H, H-7), 7.50 (s, 1 H, OH), 7.78 (s, 1 H, H-4). 19F NMR (376 MHz, CDCl3): δ (C6F6) = 74.50 (s, CF3). 13C NMR (100 MHz, CDCl3): δ = 14.02 (Me), 62.54 (CH2), 95.29 (q, 2
J
CF = 35.3 Hz, C-2), 114.74, 116.00 (CH), 117.55, 122.66 (q, 1
J
CF = 292.0 Hz, CF3), 122.68 (CH), 129.51 (CH), 133.94 (CH), 139.36 (CH), 152.62 (C-8a), 166.80 (C=O). Anal. Calcd for C13H11F3O4 (%): C, 54.18; H, 3.85; F, 19.77. Found: C, 54.20; H, 3.85; F, 19.82.
Compound 6d: light-yellow crystals; mp 120-120.5 °C (benzene). IR (mull): ν = 3230, 1686, 1619, 1578, 1527, 1345 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.43 (t, J = 7.2 Hz, 3 H, CH3), 4.42 (q, J = 7.2 Hz, 2 H,OCH2), 7.18 (br.d, J = 9.0 Hz, 1 H, H-8), 7.55 (s, 1 H, OH), 7.82 (s, 1 H, H-4), 8.23 (d, J = 2.6 Hz, 1 H, H-5), 8.29 (dd, J = 9.0, 2.6 Hz, 1 H, H-7). 19F NMR (376 MHz, CDCl3): δ (C6F6) = 74.80 (s). 13C NMR (100 MHz, CDCl3): δ = 13.82 (s, Me), 63.07 (s, OCH2), 95.96 (q, 2
J
CF = 35.8 Hz, C-2), 116.79 (s, CH), 117.13, 117.63, 122.11 (q, 1
J
CF = 291.5 Hz, CF3), 125.02 (CH), 128.81 (CH), 137.09 (CH), 142.79, 156.69 (s, C-8a), 165.98 (s, C=O). Anal. Cald for C13H10NF3O6 (%): C, 46.86; H, 3.03; F, 17.10; N, 4.20. Found: C, 46.73; H, 3.16; F, 16.97; N, 4.29.
14
General Procedure for Preparation of 7
A mixture of chromene 6 (0.5 mmol) and TsOH·H2O (10 mg, 10 mol.%) was refluxed in chlorobenzene (5 mL) for 10-17 h and then concentrated to ca. 2 mL in volume. The resulting reaction mixture was dried in vacuo, dissolved in toluene (15 mL) and washed with H2O (3 × 5 mL). Toluene solution was refluxed with a Dean-Stark trap for 5 h, the solvent was evaporated in vacuo and the residue was sublimed affording 7.
Data for Compounds 7a,d
Compound 7a: pale yellow crystals; mp 117-118 °C. IR (mull): ν = 1752, 1696, 1605, 1558 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.38-7.45 (m, 1 H, H-8, H-6), 7.70 (dd, J = 7.8, 1.6 Hz, 1 H, H-5), 7.76 (ddd, J = 8.2, 7.6, 1.6 Hz, 1 H, H-7), 8.52 (s, 1 H, H-4). 19F NMR (376 MHz, CDCl3): δ (C6F6) = 88.37 (s, CF3). 13C NMR (100 MHz, CDCl3): δ = 115. 65 (q, 1
J
CF = 290.6 Hz, CF3), 116.93 (CH), 117.24, 119.03, 125.49 (CH), 130.63 (CH), 136.25 (CH), 151.07 (C-4), 155.48 (C-8a), 155.90 (C-2), 178.36 (q, 2
J
CF = 37.7 Hz, COCF3). Anal. Calcd for C11H5F3O3 (%): C, 54.56; H, 2.08; F, 23.54. Found: C, 54.55; H, 2.30; F, 23.53.
Compound 7d: yellowish crystals; mp 115.5-116 °C (sublim.). IR (mull): ν = 1751, 1719, 1611, 1566, 1342 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.58 (dm, J = 9.1 Hz, 1 H, H-8), 8.58 (s, 1 H, H-4), 8.60 (dd, J = 9.1, 2.6 Hz, 1 H, H-7), 8.65 (d, J = 2.6 Hz, 1 H, H-5). 19F NMR (376 MHz, CDCl3): δ (C6F6) = 88.16 (s). 13C NMR (100 MHz, CDCl3): δ = 115.47 (q, 1
J
CF = 290.1 Hz, CF3), 117.15, 118.19, 118.53 (CH), 126.08 (CH), 130.06 (CH), 144.68, 149.00 (q, 4
J
CF = 1.2 Hz, C-4), 154.24 (s, C-8a), 158.55 (C-2), 177.96 (q, 2
J
CF = 38.6 Hz, COCF3). Anal. Calcd for C11H4NF3O5 (%): C, 46.01; H, 1.40; N, 4.88; F, 19.85. Found: C, 46.00; H, 1.15; N, 4.72; F, 19.94.